| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA? (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy.
InterPro is a leading global provider of business process outsourcing services. We deliver transcription services, contact center solutions, document management, enterprise portal development, employer services, medical revenue lifecycle support, and
Witham Health Services is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Witham Health Services is based in Lebanon, IN. You can find more information on Witham Health Services at www.witham.org
Moda Technology Partners is a Wayne, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.